BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1525356)

  • 1. Platelet-activating factor (PAF)-induced chemotaxis and PAF binding to human eosinophils.
    Fukuda T; Numao T; Akutsu I; Makino S
    J Lipid Mediat; 1992; 5(2):145-9. PubMed ID: 1525356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of human eosinophil chemotaxis in vitro by the anti-allergic agent emedastine difumarate.
    el-Shazly AE; Masuyama K; Samejima Y; Eura M; Ishikawa T
    Immunopharmacol Immunotoxicol; 1996 Nov; 18(4):587-95. PubMed ID: 8933171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triple role of platelet-activating factor in eosinophil migration across monolayers of lung epithelial cells: eosinophil chemoattractant and priming agent and epithelial cell activator.
    Liu L; Zuurbier AE; Mul FP; Verhoeven AJ; Lutter R; Knol EF; Roos D
    J Immunol; 1998 Sep; 161(6):3064-70. PubMed ID: 9743372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils.
    Wardlaw AJ; Moqbel R; Cromwell O; Kay AB
    J Clin Invest; 1986 Dec; 78(6):1701-6. PubMed ID: 3023451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropeptides modulate human eosinophil chemotaxis.
    Numao T; Agrawal DK
    J Immunol; 1992 Nov; 149(10):3309-15. PubMed ID: 1385521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of platelet-activating factor (PAF)-induced chemotaxis and PAF binding to human eosinophils and neutrophils by the specific ginkgolide-derived PAF antagonist, BN 52021.
    Kurihara K; Wardlaw AJ; Moqbel R; Kay AB
    J Allergy Clin Immunol; 1989 Jan; 83(1):83-90. PubMed ID: 2536413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of terfenadine on human eosinophil and neutrophil chemotactic response and generation of superoxide.
    Eda R; Townley RG; Hopp RJ
    Ann Allergy; 1994 Aug; 73(2):154-60. PubMed ID: 8067599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effects of glucocorticoids on rat eosinophil superoxide generation and chemotaxis.
    Sugimoto Y; Ogawa M; Tai N; Kamei C
    Int Immunopharmacol; 2003 Jun; 3(6):845-52. PubMed ID: 12781701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of anti-asthmatic drugs on human eosinophil chemotaxis].
    Numao T; Fukuda T; Akutsu I; Makino S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Jan; 29(1):65-71. PubMed ID: 1645817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PAF-induced eosinophil chemotaxis increases during an asthmatic attack and is inhibited by prednisolone in vivo and in vitro.
    Shindo K; Koide K; Fukumura M
    Biochem Biophys Res Commun; 1997 Aug; 237(1):146-51. PubMed ID: 9266847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of WEB 2086 on PAF-induced eosinophil chemotaxis and LTC4 production from eosinophils.
    Miyagawa H; Nabe M; Hopp RJ; Okada C; Bewtra AK; Townley G
    Agents Actions; 1992 Sep; 37(1-2):39-43. PubMed ID: 1456179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet-activating factor-induced human eosinophil transendothelial migration: evidence for a dynamic role of the endothelium.
    Casale TB; Erger RA; Little MM
    Am J Respir Cell Mol Biol; 1993 Jan; 8(1):77-82. PubMed ID: 8380250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transmigration of eosinophils through basement membrane components in vitro: synergistic effects of platelet-activating factor and eosinophil-active cytokines.
    Okada S; Kita H; George TJ; Gleich GJ; Leiferman KM
    Am J Respir Cell Mol Biol; 1997 Apr; 16(4):455-63. PubMed ID: 9115757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukotriene C4 production from human eosinophils in vitro. Role of eosinophil chemotactic factors on eosinophil activation.
    Tamura N; Agrawal DK; Townley RG
    J Immunol; 1988 Dec; 141(12):4291-7. PubMed ID: 2848892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Degranulation of human eosinophilic granulocytes by the platelet activating factor].
    Kroegel C; Venge P; Matthys H; Barnes PJ
    Pneumologie; 1990 Feb; 44 Suppl 1():234-5. PubMed ID: 2367375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative studies indicate that platelet-activating factor is a relatively weak eosinophilotactic mediator.
    Erger RA; Casale TB
    Am J Respir Cell Mol Biol; 1995 Jan; 12(1):65-70. PubMed ID: 7811471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet-activating factor-induced human eosinophil activation. Generation and release of cyclo-oxygenase metabolites in human blood eosinophils from asthmatics.
    Kroegel C; Matthys H
    Immunology; 1993 Feb; 78(2):279-85. PubMed ID: 8473016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of degranulation from human eosinophils by platelet-activating factor.
    Kroegel C; Yukawa T; Dent G; Venge P; Chung KF; Barnes PJ
    J Immunol; 1989 May; 142(10):3518-26. PubMed ID: 2541198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IgG-dependent generation of platelet-activating factor by normal and low density human eosinophils.
    Cromwell O; Wardlaw AJ; Champion A; Moqbel R; Osei D; Kay AB
    J Immunol; 1990 Dec; 145(11):3862-8. PubMed ID: 2246516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of eosinophil adherence to human vascular endothelial cells in vitro by platelet-activating factor.
    Kimani G; Tonnesen MG; Henson PM
    J Immunol; 1988 May; 140(9):3161-6. PubMed ID: 3361129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.